Las reacciones a la inyeccin fueron ms comunes con tirzepatida (8,6 %) que con semaglutida (0,3 %)
The good news is that more information on the use of GLP-1s and MHT in menopausal women is on the horizon
Board-certified FNP Licensed in 18+ states Weight Management Every weight loss plan includes the same level of care Whichever medication option you choose, your monitoring, visits, and support remain the same
The FDA removed Ozempic from the shortage list in February 2025
Before the appointment, patients should document the timing, location, and character of their muscle symptoms, any associated factors (such as relationship to exercise or time of day), and any other new symptoms